Held in partnership with the University of Edinburgh and the Journal of Parkinson’s Disease, with Edinburgh University’s Professor Tilo Kunath as chair.
Deep Brain Stimulation (DBS) is a surgical treatment for Parkinson’s that involves implanting electrodes in the brain. These electrodes produce electrical impulses that stimulate brain activity, which can help relieve Parkinson’s motor symptoms.
Presented by Edinburgh University, Journal of Parkinson’s Disease and Cure Parkinson’s, the next in this quarterly webinar series on 24th September at 5.00 pm BST will be on DBS, with a special focus on an emerging form of this therapy: adaptive DBS. Edinburgh University’s Professor Tilo Kunath will be joined by an expert panel to discuss what DBS is, how the therapy works and interacts with the brain, and whether DBS, especially adaptive DBS, could have a disease-modifying effect.
Meet our panellists
Dr Alfonso Fasano is the Chair in Neuromodulation at the University of Toronto and University Health Network. He is a Professor in the Department of Medicine (Division of Neurology) at the University of Toronto and at Humanitas University in Milan, Italy. His research focus is on the use of advanced technology, such as DBS, to treat movement disorders, including Parkinson’s, as well as the pathophysiology of the condition.
Dr Rhonda McFleder is a Tenure Track Professor in Translational Medicine at Universitätsklinikum Würzburg, Germany. Dr McFleder’s research focuses on mechanisms underlying Parkinson’s and how inflammation may play a role in progression of the condition. Her recent work has focused on how DBS interacts with the immune system, and how this may have a disease-modifying effect.
Ben Stecher is a Parkinson’s Advocate, Associate Director at The Silverstein Foundation for Parkinson’s with GBA, and Chair of the Patient Advisory Board at Rune Labs. He is also a scientific writer, co-authoring two books on Parkinson’s. Ben was one of the first patients to receive adaptive DBS from the ADAPT-PD trial in 2021.
